|
1）Khairy P, Chauvet P, Lehmann J, et al. Lower incidence of thrombus formation with cryoenergy versus radiofrequency catheter ablation. Circulation. 2003; 107: 2045-50
|
|
|
|
2）Xu J, Huang Y, Cai H, et al. Is cryoballoon ablation preferable to radiofrequency ablation for treatment of atrial fibrillation by pulmonary vein isolation? A meta-analysis. PLoS One. 2014; 9: e90323
|
|
|
|
|
|
3）Coulombe N, Paulin J, Su W. Improved in vivo performance of second-generation cryoballoon for pulmonary vein isolation. J Cardiovasc Electrophysiol. 2013; 24: 919-25
|
|
|
|
|
|
4）Straube F, Dorwarth U, Vogt J, et al. Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy. Europace. 2014; 16: 1434-42
|
|
|
|
|
|
5）Giovanni GD, Wauters K, Chierchia GB, et al. One-year follow-up after single procedure Cryoballoon ablation: a comparison between the first and second generation balloon. J Cardiovasc Electrophysiol. 2014; 25: 834-9
|
|
|
|
|
|
6）Fürnkranz A, Bordignon S, Dugo D, et al. Improved 1-year clinical success rate of pulmonary vein isolation with the second-generation cryoballoon in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2014; 25: 840-4
|
|
|
|
|
|
7）Martins RP, Hamon D, Césari O, et al. Safety and efficacy of a second-generation cryoballoon in the ablation of paroxysmal atrial fibrillation. Heart Rhythm. 2014; 11: 386-93
|
|
|
|
|
|
8）Franceschi F, Koutbi L, Mancini J, et al. Novel electromyographic monitoring technique for prevention of right phrenic nerve palsy during cryoballoon ablation. Circ Arrhythm Electrophysiol. 2013; 6: 1109-14
|
|
|
|
|
|
9）Lim HW, Cogert GA, Cameron CS, et al. Atrioesophageal Fistula During Cryoballoon Ablation for Atrial Fibrillation. J Cardiovasc Electrophysiol. 2013. Oct 31. doi: 10. 1111/jce. 12313. [Epub ahead of print]
|
|
|
|
|
|
10）Rotter M, Takahashi Y, Sanders P, et al. Reduction of fluoroscopy exposure and procedure duration during ablation of atrial fibrillation using a novel anatomical navigation system. Eur Heart J. 2005; 26: 1415-21
|
|
|
|
|
|
11）Heidbuchel H, Wittkampf FH, Vano E, et al. Practical ways to reduce radiation dose for patients and staff during device implantations and electrophysiological procedures. Europace. 2014; 16: 946-64
|
|
|
|
|
|
12）Piorkowski C, Hindricks G. Nonfluoroscopic sensor-guided navigation of intracardiac electrophysiology catheters within prerecorded cine loops. Circ Arrhythm Electrophysiol. 2011; 4: e36-8
|
|
|
|
|
|
13）Rolf S, John S, Gaspar T, et al. Catheter ablation of atrial fibrillation supported by novel nonfluoroscopic 4D navigation technology. Heart Rhythm. 2013; 10: 1293-300
|
|
|
|
|
|
14）Richter S, Döring M, Gaspar T, et al. Cardiac resynchronization therapy device implantation using a new sensor-based navigation system: results from the first human use study. Circ Arrhythm Electrophysiol. 2013; 6: 917-23
|
|
|
|
|
|
15）Della Bella P, Brugada J, Zeppenfeld K, et al. Epicardial ablation for ventricular tachycardia: a European multicenter study. Circ Arrhythm Electrophysiol. 2011; 4: 653-9
|
|
|
|
|
|
16）van Huls van Taxis CF, Wijnmaalen AP, Piers SR, et al. Real-time integration of MDCT-derived coronary anatomy and epicardial fat: impact on epicardial electroanatomic mapping and ablation for ventricular arrhythmias. JACC Cardiovasc Imaging. 2013; 6: 42-52
|
|
|
|
|
|
17）Fernández-Armenta J, Berruezo A, Andreu D, et al. Three-dimensional architecture of scar and conducting channels based on high resolution ce-CMR: insights for ventricular tachycardia ablation. Circ Arrhythm Electrophysiol. 2013; 6: 528-37
|
|
|
|
|
|
18）Arenal A, Pérez-David E, Avila P, et al. Noninvasive identification of epicardial ventricular tachycardia substrate by magnetic resonance-based signal intensity mapping. Heart Rhythm. 2014; 11: 1456-64
|
|
|
|
|